RELATIONSHIP OF GENOTYPE TO LEVEL OF HEPATITIS-C VIREMIA DETERMINED BY COMPETITIVE POLYMERASE CHAIN-REACTION

Citation
J. Hayashi et al., RELATIONSHIP OF GENOTYPE TO LEVEL OF HEPATITIS-C VIREMIA DETERMINED BY COMPETITIVE POLYMERASE CHAIN-REACTION, The Journal of infection, 30(3), 1995, pp. 235-239
Citations number
23
Categorie Soggetti
Infectious Diseases
Journal title
ISSN journal
01634453
Volume
30
Issue
3
Year of publication
1995
Pages
235 - 239
Database
ISI
SICI code
0163-4453(1995)30:3<235:ROGTLO>2.0.ZU;2-8
Abstract
To compare the levels of hepatitis C virus (HCV) viraemia in carriers of the same genotype in various stages of chronic HCV infection, we qu antified the amount of HCV RNA by competitive polymerase chain reactio n and determined HCV genotype using type-specific primers. The study p opulation included 255 patients with chronic HCV infection (asymptomat ic 33, chronic hepatitis 141, liver cirrhosis 50, hepatocellular carci noma 31). Of these 255, the prevalence of HCV RNA genotype II was 67.8 %, genotype III, 17.3% and genotpye IV, 14.9%; no genotype I was found . The level of HCV RNA (logarithmic transformed copy numbers per 50 mu l of serum) was significantly higher in subjects of genotype Il than in those of genotypes III or IV (mean titre 5.8 +/- 1.0 vs, 5.1 +/- 1. 2 and 4.8 +/- 1.1, P<0.05, respectively). There was no significant dif ference in the level of HCV RNA between genotypes III and IV. Of 173 p atients of genotype II, there were no significant differences between the level of HCV RNA and the stage of liver disease or in the level of HCV RNA by age. Of the 129 with genotype II with a history of blood t ransfusion, there was no significant difference between the level of H CV RNA of patients with and without a history of transfusion or betwee n that of patients with a history of blood transfusion and the time el apsed since blood transfusion. The level of HCV viraemia depended on t he genotype of HCV RNA and did not correlate to age or to the stage of liver disease. We conclude that the genotype of HCV RNA should be giv en attention in order to provide more effective treatment.